![SLG - SL Green Realty Corp - Stock Price Chart]() |
Market Cap | 4.58B | EPS (ttm) | -0.55 |
P/E | - | EPS this Y | -1096.29% |
Forward P/E | - | EPS next Y | 7.97% |
PEG | - | EPS past 5Y | -52.62% |
P/S | 4.72 | EPS next 5Y | - |
P/B | 1.20 | EPS Q/Q | -290.82% |
Dividend | 5.13% | Sales Q/Q | 2.01% |
Insider Own | 6.66% | Inst Own | 81.72% |
Insider Trans | -0.12% | Inst Trans | -2.41% |
Short Float | 9.13% | Earnings | Jul 16/a |
Analyst Recom | 2.67 | Target Price | 63.65 |
Avg Volume | 993.28K | 52W Range | 45.15 - 82.81 |
|
|
|
SL Green Realty Corp. is a real estate investment trust, which engages in the acquisition, development, ownership, management, and operation of commercial real estate properties and principally office properties. It operates through the following segments Real Estate, Debt and Preferred Equity Investments (DPE), and SUMMIT. The company was founded by Stephen L. Green in June 1997 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Brown Carol N | Director | Jul 18 '25 | Sale | 60.61 | 2,500 | 151,525 | 937 | Jul 18 04:20 PM | Brown Carol N | Director | Jul 18 '25 | Proposed Sale | 60.10 | 2,500 | 150,261 | | Jul 18 02:45 PM | HATKOFF CRAIG M | Director | Jan 24 '25 | Sale | 66.30 | 3,455 | 229,066 | 2,052 | Jan 27 05:46 PM | HATKOFF CRAIG M | Director | Jan 24 '25 | Proposed Sale | 66.21 | 3,455 | 228,753 | | Jan 24 04:27 PM | LEVINE ANDREW S | CHIEF LEGAL OFFICER & GC | Nov 25 '24 | Sale | 79.69 | 45,785 | 3,648,463 | 8,104 | Nov 26 05:39 PM |
|
|
 |
![PATH - UiPath Inc - Stock Price Chart]() |
Market Cap | 6.74B | EPS (ttm) | -0.12 |
P/E | - | EPS this Y | 3.77% |
Forward P/E | 20.32 | EPS next Y | 12.65% |
PEG | - | EPS past 5Y | 33.36% |
P/S | 4.64 | EPS next 5Y | 8.75% |
P/B | 3.96 | EPS Q/Q | 18.45% |
Dividend | - | Sales Q/Q | 6.42% |
Insider Own | 23.57% | Inst Own | 58.44% |
Insider Trans | -1.61% | Inst Trans | 4.95% |
Short Float | 14.37% | Earnings | May 29/a |
Analyst Recom | 2.70 | Target Price | 14.39 |
Avg Volume | 10.57M | 52W Range | 9.38 - 15.93 |
|
|
|
UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Dines Daniel | CEO and Chairman | Jul 18 '25 | Sale | 12.38 | 45,000 | 557,154 | 4,968,376 | Jul 18 04:18 PM | Dines Daniel | CEO and Chairman | Jul 17 '25 | Sale | 12.45 | 45,000 | 560,142 | 5,013,376 | Jul 17 04:32 PM | Dines Daniel | CEO and Chairman | Jul 16 '25 | Sale | 12.43 | 45,000 | 559,206 | 5,058,376 | Jul 16 04:13 PM | Dines Daniel | CEO and Chairman | Jul 15 '25 | Sale | 12.50 | 45,000 | 562,612 | 5,103,376 | Jul 15 04:13 PM | Dines Daniel | CEO and Chairman | Jul 14 '25 | Sale | 12.44 | 45,000 | 559,593 | 5,148,376 | Jul 14 05:11 PM |
|
|
 |
![CARG - CarGurus Inc - Stock Price Chart]() |
Market Cap | 3.28B | EPS (ttm) | 0.36 |
P/E | 93.04 | EPS this Y | 24.76% |
Forward P/E | 13.55 | EPS next Y | 14.05% |
PEG | 4.87 | EPS past 5Y | -11.88% |
P/S | 3.63 | EPS next 5Y | 19.11% |
P/B | 8.13 | EPS Q/Q | 89.50% |
Dividend | - | Sales Q/Q | 4.34% |
Insider Own | 18.43% | Inst Own | 88.70% |
Insider Trans | -7.29% | Inst Trans | 2.21% |
Short Float | 4.05% | Earnings | May 08/a |
Analyst Recom | 1.80 | Target Price | 38.58 |
Avg Volume | 876.08K | 52W Range | 21.65 - 41.33 |
|
|
|
Cargurus, Inc. is an online automotive platform, which engages in buying and selling vehicles that is building upon its listings marketplace with digital retail solutions and the CarOffer digital wholesale platform. It operates through the following segments: U.S. Marketplace, Digital Wholesale, and Other. The U.S. Marketplace segment offers marketplace services from customers. The Digital Wholesale segment consists of dealer-to-dealer and IMCO services and products which are sold on the CarOffer platform. The company was founded by Langley Steinert on November 10, 2005 and is headquartered in Boston, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Zales Samuel | COO and President | Jul 16 '25 | Sale | 33.88 | 10,000 | 338,800 | 461,821 | Jul 18 04:17 PM | Hallowell Zachary Emerson | CEO, CarOffer | Jul 17 '25 | Sale | 33.84 | 1,733 | 58,645 | 117,045 | Jul 18 04:15 PM | Hallowell Zachary Emerson | Officer | Jul 17 '25 | Proposed Sale | 33.84 | 1,733 | 58,645 | | Jul 17 11:34 AM | Zales Samuel | Officer | Jul 16 '25 | Proposed Sale | 33.88 | 10,000 | 338,800 | | Jul 16 03:31 PM | Zamora Javier | General Counsel and Secretary | Jul 10 '25 | Sale | 35.00 | 6,154 | 215,390 | 92,807 | Jul 14 04:11 PM |
|
|
|  |
![PBYI - Puma Biotechnology Inc - Stock Price Chart]() |
Market Cap | 168.77M | EPS (ttm) | 0.77 |
P/E | 4.42 | EPS this Y | -21.77% |
Forward P/E | 14.47 | EPS next Y | -51.55% |
PEG | - | EPS past 5Y | - |
P/S | 0.73 | EPS next 5Y | -25.63% |
P/B | 1.74 | EPS Q/Q | 159.66% |
Dividend | - | Sales Q/Q | 5.12% |
Insider Own | 24.76% | Inst Own | 53.60% |
Insider Trans | -1.25% | Inst Trans | 3.99% |
Short Float | 7.05% | Earnings | May 08/a |
Analyst Recom | 4.00 | Target Price | 3.00 |
Avg Volume | 352.64K | 52W Range | 2.22 - 4.13 |
|
|
|
Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Cesano Alessandra | Director | Jul 18 '25 | Proposed Sale | 3.37 | 27,000 | 90,909 | | Jul 18 04:16 PM | NOUGUES MAXIMO F | Chief Financial Officer | Jul 08 '25 | Sale | 3.53 | 5,587 | 19,739 | 208,164 | Jul 10 08:56 PM | NOUGUES MAXIMO F | Chief Financial Officer | Jul 09 '25 | Sale | 3.54 | 3,935 | 13,910 | 204,229 | Jul 10 08:56 PM | HUNT DOUGLAS M | See Remarks | Jul 08 '25 | Sale | 3.53 | 4,374 | 15,453 | 168,337 | Jul 10 08:52 PM | HUNT DOUGLAS M | See Remarks | Jul 09 '25 | Sale | 3.54 | 3,443 | 12,171 | 164,894 | Jul 10 08:52 PM |
|
|
 |
![SRRK - Scholar Rock Holding Corp - Stock Price Chart]() |
Market Cap | 3.87B | EPS (ttm) | -2.65 |
P/E | - | EPS this Y | -7.25% |
Forward P/E | - | EPS next Y | 25.71% |
PEG | - | EPS past 5Y | -5.90% |
P/S | - | EPS next 5Y | 38.77% |
P/B | 12.37 | EPS Q/Q | -12.68% |
Dividend | - | Sales Q/Q | - |
Insider Own | 23.62% | Inst Own | 96.95% |
Insider Trans | -2.03% | Inst Trans | 3.04% |
Short Float | 19.60% | Earnings | May 14/b |
Analyst Recom | 1.00 | Target Price | 51.00 |
Avg Volume | 1.25M | 52W Range | 6.76 - 46.98 |
|
|
Jul-17-25 | Initiated |
Cantor Fitzgerald |
Overweight |
|
|
|
Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
FLIER JEFFREY S. | Director | Jul 16 '25 | Sale | 40.02 | 11,136 | 445,688 | 0 | Jul 18 04:15 PM | Qatanani Mo | CHIEF SCIENTIFIC OFFICER | Jul 08 '25 | Sale | 34.44 | 24,066 | 828,898 | 115,495 | Jul 10 09:46 PM | Mohammed Qatanani | Officer | Jul 08 '25 | Proposed Sale | 35.48 | 24,066 | 853,862 | | Jul 08 04:12 PM | FLIER JEFFREY S. | Director | Jun 23 '25 | Option Exercise | 21.62 | 20,316 | 439,232 | 44,386 | Jun 25 04:30 PM | FLIER JEFFREY S. | Director | Jun 23 '25 | Sale | 32.24 | 20,316 | 654,904 | 24,070 | Jun 25 04:30 PM |
|
|
|  |
![MS - Morgan Stanley - Stock Price Chart]() |
Market Cap | 225.05B | EPS (ttm) | 8.83 |
P/E | 15.96 | EPS this Y | 10.69% |
Forward P/E | 14.73 | EPS next Y | 8.63% |
PEG | 1.71 | EPS past 5Y | 8.89% |
P/S | 2.06 | EPS next 5Y | 9.32% |
P/B | 2.29 | EPS Q/Q | 16.64% |
Dividend | 2.75% | Sales Q/Q | 10.92% |
Insider Own | 23.60% | Inst Own | 62.53% |
Insider Trans | -0.09% | Inst Trans | 1.61% |
Short Float | 1.21% | Earnings | Jul 16/b |
Analyst Recom | 2.44 | Target Price | 141.72 |
Avg Volume | 5.89M | 52W Range | 90.94 - 145.16 |
|
|
|
Morgan Stanley operates as a global financial services company. The firm provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following segments: Institutional Securities, Wealth Management, and Investment Management. The Institutional Services segment provides financial advisory, capital-raising services, and related financing services on behalf of institutional investors. The Wealth Management segment offers brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed-income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs. The Investment Management segment provides equity, fixed income, alternative investments, real estate, and merchant banking strategies. The company was founded by Harold Stanley and Henry S. Morgan in 1924 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
YESHAYA SHARON | Chief Financial Officer | Jul 17 '25 | Sale | 139.81 | 25,583 | 3,576,706 | 0 | Jul 18 04:13 PM | SMITH CHARLES A | Chief Risk Officer | Jul 17 '25 | Sale | 140.30 | 20,000 | 2,805,918 | 119,239 | Jul 18 04:12 PM | SIMKOWITZ DANIEL A | Co-President | Jul 17 '25 | Sale | 141.13 | 29,000 | 4,092,628 | 399,105 | Jul 18 04:11 PM | SAPERSTEIN ANDREW M | Co-President | Jul 17 '25 | Sale | 140.97 | 43,566 | 6,141,714 | 0 | Jul 18 04:10 PM | MORGAN STANLEY SMITH BARNEY LL | Indirectly controlled by the i | Jul 18 '25 | Proposed Sale | 140.76 | 3,370 | 474,368 | | Jul 18 04:09 PM |
|
|
 |
![TEAM - Atlassian Corporation - Stock Price Chart]() |
Market Cap | 51.30B | EPS (ttm) | -1.65 |
P/E | - | EPS this Y | 20.83% |
Forward P/E | 46.57 | EPS next Y | 18.20% |
PEG | - | EPS past 5Y | 15.38% |
P/S | 10.34 | EPS next 5Y | 20.74% |
P/B | 37.46 | EPS Q/Q | -653.59% |
Dividend | - | Sales Q/Q | 14.09% |
Insider Own | 38.51% | Inst Own | 56.13% |
Insider Trans | -1.92% | Inst Trans | 1.86% |
Short Float | 3.87% | Earnings | Aug 07/a |
Analyst Recom | 1.62 | Target Price | 274.80 |
Avg Volume | 2.36M | 52W Range | 135.29 - 326.00 |
|
|
|
Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Cannon-Brookes Michael | CEO, Co-Founder | Jul 17 '25 | Sale | 192.60 | 7,665 | 1,476,244 | 398,580 | Jul 18 04:13 PM | Farquhar Scott | Director | Jul 17 '25 | Sale | 192.60 | 7,665 | 1,476,244 | 398,580 | Jul 18 04:07 PM | Cannon-Brookes Michael | CEO, Co-Founder | Jul 16 '25 | Sale | 189.37 | 7,665 | 1,451,517 | 406,245 | Jul 17 06:14 PM | Farquhar Scott | Director | Jul 16 '25 | Sale | 189.37 | 7,665 | 1,451,518 | 406,245 | Jul 17 06:14 PM | Cannon-Brookes Michael | CEO, Co-Founder | Jul 15 '25 | Sale | 189.70 | 7,665 | 1,454,055 | 413,910 | Jul 16 05:31 PM |
|
|
|  |
![MRVL - Marvell Technology Inc - Stock Price Chart]() |
Market Cap | 64.36B | EPS (ttm) | -0.57 |
P/E | - | EPS this Y | 77.82% |
Forward P/E | 20.94 | EPS next Y | 27.67% |
PEG | - | EPS past 5Y | - |
P/S | 9.90 | EPS next 5Y | 40.29% |
P/B | 4.83 | EPS Q/Q | 181.54% |
Dividend | 0.33% | Sales Q/Q | 63.26% |
Insider Own | 0.50% | Inst Own | 83.99% |
Insider Trans | -1.24% | Inst Trans | -1.59% |
Short Float | 2.93% | Earnings | May 29/a |
Analyst Recom | 1.36 | Target Price | 90.35 |
Avg Volume | 20.64M | 52W Range | 47.08 - 127.48 |
|
|
|
Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
MARK J.& STEPHANIE CASPER TRUS | Officer | Jul 18 '25 | Proposed Sale | 72.35 | 3,000 | 217,050 | | Jul 18 04:12 PM | Bharathi Sandeep | President, Data Center Group | Jul 15 '25 | Option Exercise | 0.00 | 11,465 | 0 | 71,040 | Jul 17 05:07 PM | Koopmans Chris | President and COO | Jul 15 '25 | Option Exercise | 0.00 | 11,360 | 0 | 100,046 | Jul 17 05:06 PM | MURPHY MATTHEW J | Chairman of the Board and CEO | Jul 15 '25 | Option Exercise | 0.00 | 20,896 | 0 | 259,464 | Jul 17 05:05 PM | Casper Mark | EVP & Chief Legal Officer | Jul 15 '25 | Option Exercise | 0.00 | 6,857 | 0 | 5,072 | Jul 17 04:24 PM |
|
|
 |
![JNJ - Johnson & Johnson - Stock Price Chart]() |
Market Cap | 393.87B | EPS (ttm) | 9.35 |
P/E | 17.51 | EPS this Y | 8.57% |
Forward P/E | 14.39 | EPS next Y | 4.98% |
PEG | 2.62 | EPS past 5Y | 0.55% |
P/S | 4.35 | EPS next 5Y | 6.68% |
P/B | 5.04 | EPS Q/Q | 18.30% |
Dividend | 3.09% | Sales Q/Q | 5.77% |
Insider Own | 0.14% | Inst Own | 73.60% |
Insider Trans | -1.16% | Inst Trans | 1.15% |
Short Float | 0.66% | Earnings | Jul 16/b |
Analyst Recom | 2.24 | Target Price | 176.79 |
Avg Volume | 8.15M | 52W Range | 140.68 - 169.99 |
|
|
|
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
REED JOHN C | EVP, Innovative Medicine, R&D | Jul 17 '25 | Sale | 163.55 | 19,137 | 3,129,830 | 10,658 | Jul 18 04:12 PM | REED JOHN C | Officer | Jul 17 '25 | Proposed Sale | 163.55 | 19,137 | 3,129,831 | | Jul 17 04:05 PM | REED JOHN C | EVP, Innovative Medicine, R&D | May 01 '25 | Option Exercise | 0.00 | 25,255 | 0 | 40,797 | May 05 05:10 PM | Decker Robert J | VP Corporate Controller | Feb 25 '25 | Option Exercise | 101.87 | 6,999 | 712,988 | 28,000 | Feb 26 06:42 PM | Decker Robert J | VP Corporate Controller | Feb 25 '25 | Sale | 165.88 | 6,999 | 1,160,994 | 21,001 | Feb 26 06:42 PM |
|
|
 |
![COHR - Coherent Corp - Stock Price Chart]() |
Market Cap | 15.48B | EPS (ttm) | -0.23 |
P/E | - | EPS this Y | 109.27% |
Forward P/E | 22.09 | EPS next Y | 29.04% |
PEG | - | EPS past 5Y | - |
P/S | 2.77 | EPS next 5Y | 50.73% |
P/B | 2.89 | EPS Q/Q | 62.50% |
Dividend | - | Sales Q/Q | 23.91% |
Insider Own | 1.14% | Inst Own | 92.31% |
Insider Trans | -3.08% | Inst Trans | -0.60% |
Short Float | 5.40% | Earnings | May 07/a |
Analyst Recom | 1.48 | Target Price | 101.50 |
Avg Volume | 3.04M | 52W Range | 45.58 - 113.60 |
|
|
|
Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Koeppen Christopher | EVP of Aerospace & Defense | Jul 16 '25 | Sale | 96.45 | 5,458 | 526,436 | 45,124 | Jul 18 04:09 PM | Koeppen Christopher | EVP of Aerospace & Defense | Jul 17 '25 | Sale | 100.00 | 3,100 | 310,000 | 42,024 | Jul 18 04:09 PM | CHRISTOPHER KOEPPEN | Officer | Jul 17 '25 | Proposed Sale | 97.82 | 3,100 | 303,242 | | Jul 17 04:20 PM | CHRISTOPHER KOEPPEN | Officer | Jul 16 '25 | Proposed Sale | 96.07 | 5,458 | 524,350 | | Jul 16 04:19 PM | Xia Howard H. | Director | Jun 16 '25 | Option Exercise | 17.84 | 1,000 | 17,840 | 48,747 | Jun 16 05:30 PM |
|
|
|